Is Sensory Stimulation Effective in Reducing Time Spent in a Coma or Vegetative State
Launched by BAYSIDE HEALTH · Sep 12, 2005
Trial Information
Current as of July 09, 2025
Unknown status
Keywords
ClinConnect Summary
A randomised control trial of patients who have a severe brain injury to determine if patients who receive a standardised sensory stimulation program emerge earlier from a vegetative state. The experimental group would receive, in addition to their normal occupational therapy, sensory stimulation which would involve the daily application of stimulation to all five senses using the Sensory Modalities Assessment and Rehabilitation Technique (SMART).
The SMART is both an assessment and treatment too. Patients in both groups will have baseline assessments conducted using the SMART, with furthe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • admitted with severe brain injury
- • GCS of 9 or less. A GCS score of 9 or less is indicative of a severe brain injury
- • medically stable, as documented by medical staff
- • age 18 to 65 years
- • controlled intracranial pressure no sedation
- • no previous brain injury
- • Exclusion Criteria
- • patient declared brain dead
- • next of kin withdraws patient from the study
- • withdrawal of consent by patient on waking
- • raised uncontrolled intracranial pressure, following discussions with treating medical team
- • patient enrolled in DECRA or RSI Trials
About Bayside Health
Bayside Health is a leading clinical trial sponsor dedicated to advancing medical research and innovation through rigorous and ethical study design. With a focus on improving patient outcomes, Bayside Health collaborates with healthcare professionals, researchers, and institutions to conduct high-quality clinical trials across a diverse range of therapeutic areas. Committed to transparency and regulatory compliance, the organization prioritizes patient safety and data integrity, ensuring that all trials contribute valuable insights to the medical community and enhance the development of new treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Jacqui M Morarty, Occupational Therapist
Principal Investigator
Bayside Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials